Here is MY thoughts as to why the company doesn’t speak of Renesas.
They are part of an industry that is extremely competitive and therefore very sensitive when it comes to confidentiality. It would be inconceivable on other exchanges to be required to disclose the name of a customer or a new agreement. I can only speculate as to why the ASX ignores how critical confidentiality is in the world of tech, but the fact is, they don’t respect it. When any technology producer chooses a critical, strategic, supplier, they do not want the world to know as it makes a very clear statement as to the direction they are going with their product development. This is especially true when they choose a company like Brainchip that is so specialized. Im sure they are proud and grateful to be an ASX listed company but these requirements put them in a very awkward situation. They will always do what is legally required but if they appear vague at times, that is why. I hope you can understand this
of course it’s all IMO
happy Friday people.
- Forums
- ASX - By Stock
- BRN
- 2020 BRN Discussion
2020 BRN Discussion, page-28962
-
- There are more pages in this discussion • 352 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $361.9M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $878.2K | 4.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 388739 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
62 | 1344164 | 0.195 |
62 | 1739410 | 0.190 |
33 | 1759832 | 0.185 |
50 | 1530443 | 0.180 |
16 | 598862 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 337097 | 7 |
0.205 | 914687 | 15 |
0.210 | 1398298 | 25 |
0.215 | 506951 | 23 |
0.220 | 758461 | 24 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online